Industry Insights
-
The Guide To Understanding The Impact On Cost Of Poor Quality
2/4/2025
This guide unveils the hidden financial burdens of subpar products and provides a roadmap to improvement. Explore nine distinct categories of poor-quality costs and learn strategies to mitigate them.
-
Dry Powdered Medium Milling Equivalency Study
9/26/2022
An assessment of the physical, chemical, and biological characteristics of representative complex media and feeds was made to compare pin mills and overall dry powdered medium manufacturing processes.
-
Exploring The Genetic Tools Enabling Protein Expression In Fruit Flies
9/26/2026
Fruit fly genetics enables precise, scalable protein expression through stable integration, targeted control, inducible regulation, and heritable systems.
-
From Day One Success To Everyday Improvement: The OR → OE Continuum
11/24/2025
Bridging the gap between initial startup and long-term sustainability requires a unified strategy. Learn to transform early readiness metrics into a durable operating system that drives continuous performance improvements.
-
Are Drugs Becoming More Lipophilic Over Time?
Get a deeper look into how drug lipophilicity has evolved over time, its impact on drug development, and the need for new technology to enable new more complex drugs.
-
Controls For Retrieval-Augmented Generation In GxP
9/1/2026
Validation teams deal with inherent variability all the time. The same principles for GMP — think visual inspection — can apply to probabilistic AI systems.
-
Introduction To The 3 Pillars
8/1/2023
To optimize and standardize cell line development that benefits downstream work, organizations must focus on technology and expertise in three key areas: automation, analytics, and digitalization.
-
FDA's COVID-19 PREPP Initiative Summary Report — Key Takeaways For Manufacturers
2/19/2021
Published in January 2021, the FDA COVID-19 Pandemic Recovery and Preparedness Plan (PREPP) Initiative Summary Report is the culmination of work performed by the FDA’s PREPP Initiative, which launched in April 2020 to examine lessons learned from the agency’s response to the global COVID-19 pandemic. This article provides a brief overview of the report’s overarching themes and highlights key regulatory insights for manufacturers in light of two action areas in particular.
-
Innovations In Peptide Manufacturing
1/23/2025
The peptide manufacturing industry is evolving to meet the demands of efficiency, scalability, and sustainability. Learn how the latest innovations are addressing these challenges.
-
A Practical Guide To Autologous CAR T Manufacturing
6/19/2026
Early process decisions shape scalability, consistency, and compliance in autologous CAR T manufacturing. Learn where variability emerges across the workflow and how to plan ahead.